Literature DB >> 7370207

Dietary tryptophan level and the enzymes of tryptophan NAD pathway.

U Satyanarayana, B S Rao.   

Abstract

1. Dietary tryptophan was found to regulate the activities of tryptophan oxygenase (EC 1.13.1.12) and quinolinate phosphoribosyltransferase (EC 2.4.2a) in liver. 2. With increasing tryptophan concentration in the diet containing 100 g protein/kg, tryptophan oxygenase activity increased while that of quinolinate phosphoribosyltransferase decreased. The response of these enzymes to dietary tryptophan at lower dietary protein level (25 g/kg) was not significant. 3. Liver nicotinate phosphoribosyltransferase (EC 2.4.2.11) activity and kidney picolinate carboxylase (EC 4.1.1.45) activity were unaltered with different tryptophan concentrations in the diet. 4. The response of various biochemical measurements was dependent on the tryptophan intake and the changes were marked below and above the requirement level of tryptophan. 5. It is suggested that the urinary excretion of quinolinic acid and N'-methylnicotinamide may be useful in assessing the tryptophan nutritional status and its requirement.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370207     DOI: 10.1079/bjn19800070

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  4 in total

Review 1.  Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.

Authors:  Carles Cantó; Anthony A Sauve; Peter Bai
Journal:  Mol Aspects Med       Date:  2013-01-25

Review 2.  Neuropsychiatric disorders related to interferon and interleukins treatment.

Authors:  Aye Mu Myint; Markus J Schwarz; Harry W M Steinbusch; Brian E Leonard
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584

3.  Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice.

Authors:  Masaaki Kanai; Hiroshi Funakoshi; Hisaaki Takahashi; Tomoko Hayakawa; Shinya Mizuno; Kunio Matsumoto; Toshikazu Nakamura
Journal:  Mol Brain       Date:  2009-03-27       Impact factor: 4.041

Review 4.  Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders.

Authors:  Maria Grazia Perrone; Antonella Centonze; Morena Miciaccia; Savina Ferorelli; Antonio Scilimati
Journal:  Molecules       Date:  2020-11-18       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.